Demonetisation, Swachh Bharat Abhiyan, Make in India, Digital India, Ayushmaan Bharat and implementation of GST have been the major highlights of the BJP-led government. The government also initiated policies and invited many foreign investors to boost exports. Ayushmaan Bharat is another recognised initiative and may have the potential to be a game changer in the industry. The government has also initiated scaling up the Jan-Aushadhi scheme across India to provide generic drugs to the masses at a low cost with easy accessibility. However, the momentum that it gained is slower than what was expected. Industry experts highlight the hits and misses of the present NDA government and share their expectations from the new administration. BY USHA SHARMA
âWe expect further fine tuning of the existing schemes and policiesâ
âHoping that the future of Indian Pharma is brighter than beforeâ
âI expect more bold initiatives on macro-economic frontâ
âFunding for pharma companies might be a way to move forwardâ
âThere is a definite need to support SME upgradationâ
âWe expect the new govt to reduce regulatory interventionâ
Comments are closed.